MOTS-c: What Lakeland Readers Should Know

MOTS-c is a small peptide that your own mitochondria make. It is promoted online for energy, fat loss and slower aging, but the research behind those claims comes from mice. No study has tested MOTS-c as a treatment in people. This page explains what is known. It is general information, not advice for your situation.

What it is and how it works

Mitochondria are the parts of your cells that turn food into usable energy. They carry a small set of their own genes. MOTS-c is a chain of 16 amino acids encoded in one of those mitochondrial genes. Researchers first described it in 2015. It is found in muscle, heart and brain, and it circulates in the blood of people and rodents. Products sold today are lab-made copies.¹

In cells and mice, MOTS-c appears to shift how cells use fuel, partly through AMPK, an enzyme that acts as the cell’s energy sensor. FDA notes that its direct target is still unknown.¹

There is also a practical problem. In test-tube studies, MOTS-c broke down quickly in human blood. FDA says it “remains to be determined” whether injected MOTS-c can reach active levels in people.¹

What the research shows (and where evidence is weak)

• No human treatment studies. In its May 2026 review, FDA said it did not find any studies that gave MOTS-c to people.¹
• Human studies measure the body’s own MOTS-c. In one study of 10 healthy young men who did not exercise much, a hard cycling session raised MOTS-c in muscle about 12-fold and in blood about 1.5-fold. Blood levels returned to normal within 4 hours.² This shows exercise changes natural MOTS-c levels. It does not test MOTS-c as a drug.
• Mouse studies. In one study, MOTS-c injections started very late in life in old male mice improved their physical capacity and modestly extended lifespan (median 970 days vs 912 days).¹ That result comes from one study in one strain and sex of mouse.
• FDA’s caution. FDA says the animal studies so far were limited to rodents and did not test how effects change with dose, so “the findings should be interpreted with caution.”¹

FDA found MOTS-c marketed online for mitochondrial energy, weight loss, blood sugar, physical performance, DNA repair and slowing cellular aging.¹ None of these uses has been tested in people.

FDA and regulatory status

As of the dates below, MOTS-c is not FDA-approved for any use. It has no official drug-quality standard (USP monograph) and is not part of any approved drug.¹

• FDA’s review. In an evaluation dated May 11, 2026, FDA staff recommended against adding MOTS-c to the 503A Bulks List, the list of unapproved ingredients that licensed pharmacies may use to make custom drugs. FDA cited poor characterization, no animal safety studies and no human safety or effectiveness data.¹
• The July 2026 vote. An FDA advisory committee narrowly voted on July 23, 2026 to recommend adding MOTS-c. FDA’s own reviewers had recommended against it, and the vote is not binding. The vote was reported as 7 to 5 with 2 abstentions.³⁴ As of November 2026, FDA had posted no minutes or final decision.⁵
• FDA’s safety list. By April 22, 2026, the compounding nominations for MOTS-c had been withdrawn, but FDA still lists its safety concerns, including possible immune reactions and no human exposure data.⁶
• The 2026 HHS draft policy. As of November 13, 2026, HHS has published a draft, non-binding policy saying it does not intend to take enforcement action against licensed pharmacies compounding certain peptides in certain forms. This is not FDA approval, and FDA has not added these peptides to its official list.⁷ According to law-firm summaries of the draft, the peptides are BPC-157, TB-500, epitalon, semax, KPV and MOTS-c, with MOTS-c limited to injected forms. The reported conditions include a patient-specific prescription, a single active ingredient and ingredients from an FDA-registered source.⁸⁹ The comment period closed on November 13, 2026. As of November 13, 2026, a final policy had not been published. Check the Federal Register notice for updates.⁷
• Sport. The World Anti-Doping Agency (WADA) 2026 list names MOTS-c as a banned metabolic modulator, prohibited at all times.¹⁰

Our guide to whether peptides are legal in Florida explains how these rules fit together.

Common side effects and safety

FDA states that the potential risks of MOTS-c in humans “are unknown.”¹ Specifically:

• There are no human safety studies and no data on how the body absorbs or clears it.¹
• There are no animal toxicology studies.¹
• FDA’s adverse-event database had no reports, through March 2025.¹ With so little use on record, that tells us very little.
• FDA raises a possible risk of immune reactions to injected peptides.¹

Products sold as “research chemicals” are not made or tested for human use. See our guide to research-chemical peptide risks.

Typical cost range

There is no reliable price data. MOTS-c is not an approved product, so it has no official list price. Cost would depend on where the product comes from, how it is made and tested, how long it is used, and any visit or membership fees. Prices vary between clinics and pharmacies. Ask any provider for a written price breakdown before you start.

Our cost guide lists questions to ask about pricing.

Questions to ask a provider

• What human evidence supports MOTS-c for my goal, given that it has not been tested as a treatment in people?
• Which licensed pharmacy makes the product, and how does it meet the conditions of current federal policy?
• How is the product tested for identity, purity and sterility?
• What side effects should I watch for, and how will you track them?
• Are there options with stronger human evidence for my goal?
• What is the total cost, and what does it include?

Our guide on how to vet a peptide clinic can help you spot red flags.